MaxCyte Inc
NASDAQ:MXCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Friday's Dog Holdings Inc
XTSX:DOGS
|
CA |
|
San-Ai Obbli Co Ltd
TSE:8097
|
JP |
|
Giglio Group SpA
MIL:GG
|
IT |
|
Taylor Wimpey PLC
OTC:TWODY
|
UK |
|
Weed Inc
OTC:BUDZ
|
US |
|
Solstice Gold Corp
XTSX:SGC
|
CA |
|
Odyssey Semiconductor Technologies Inc
OTC:ODII
|
US |
|
M
|
Modiv Inc
NYSE:MDV
|
US |
|
A
|
Australian Vanadium Ltd
OTC:ATVVF
|
AU |
|
H
|
Hera SpA
XBER:HE9
|
IT |
|
Founding Construction Development Co Ltd
TWSE:5533
|
TW |
|
NPO Nauka PAO
MOEX:NAUK
|
RU |
|
H
|
Havila Shipping ASA
OSE:HAVI
|
NO |
|
H
|
Hexindo Adiperkasa Tbk PT
F:HX1A
|
ID |
|
Ehime Bank Ltd
TSE:8541
|
JP |
|
Elcom International Inc
OTC:ELCO
|
US |
|
J
|
J B Hunt Transport Services Inc
XBER:JB1
|
US |
|
CalAmp Corp
OTC:CAMPQ
|
US |
|
Shenzhen Refond Optoelectronics Co Ltd
SZSE:300241
|
CN |
|
NewOrigin Gold Corp
XTSX:NEWO
|
CA |
|
A
|
Agencia Comercial Spirits Ltd
NASDAQ:AGCC
|
TW |
|
R
|
Reitar Logtech Holdings Ltd
NASDAQ:RITR
|
HK |
MaxCyte Inc
Intangible Assets
MaxCyte Inc
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MaxCyte Inc
NASDAQ:MXCT
|
Intangible Assets
$650k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Intangible Assets
$15.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Danaher Corp
NYSE:DHR
|
Intangible Assets
$17.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
|
Waters Corp
NYSE:WAT
|
Intangible Assets
$558.2m
|
CAGR 3-Years
35%
|
CAGR 5-Years
17%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Intangible Assets
$426m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-2%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Intangible Assets
$5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
30%
|
|
MaxCyte Inc
Glance View
MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. The company is headquartered in Gaithersburg, Maryland. The company went IPO on 2016-03-29. The firm is focused on providing enabling platform technologies to advance cell-based research and development, as well as next-generation cell therapeutic discovery, development and commercialization. The firm has developed and commercialized its Flow Electroporation platform, which facilitates complex engineering of a variety of cells. Its ExPERT platform is based on its Flow Electroporation technology, which has been designed to address the cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. Its ExPERT platform consists of three instruments, which are known as the ATx, STx and GTx. The firm has also developed CARMA, a therapeutic platform based on transfecting mRNA into unstimulated cells for the development of immune cell therapies.
See Also
What is MaxCyte Inc's Intangible Assets?
Intangible Assets
650k
USD
Based on the financial report for Dec 31, 2025, MaxCyte Inc's Intangible Assets amounts to 650k USD.
